Trials / Conditions / Non-metastatic Prostate Cancer

Non-metastatic Prostate Cancer

10 registered clinical trials studyying Non-metastatic Prostate Cancer — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Assess Alpha DaRT224 for the Treatment of Men With Non-metastatic Locally Recurrent Prostate Cancer NCT06202248	Alpha Tau Medical LTD.	N/A
Completed	An Observational Study to Learn More About the Use of Androgen Receptor Inhibitors and How They Affect Men Wit NCT06204302	Bayer	—
Active Not Recruiting	Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer NCT05617885	Praful Ravi, MB BCHir, MRCP	Phase 1
Active Not Recruiting	Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide NCT04335682	Alliance Foundation Trials, LLC.	Phase 2
Completed	PROState Pathway Embedded Comparative Trial NCT04400656	Imperial College London	—
Completed	Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer NCT04049747	Imperial College London	N/A
Completed	Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate NCT00239291	AstraZeneca	Phase 1 / Phase 2
Completed	Casodex vs Placebo in Non-Metastatic Early Prostate Cancer NCT00672282	AstraZeneca	Phase 3
Completed	(Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer NCT00673205	AstraZeneca	Phase 3
Completed	Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer NCT00657904	AstraZeneca	Phase 3